Listed

Amphenol Corp: Form 10-Q for the period ended Jun 30, 2020

Filed with the SEC on Jul 24, 2020 and accepted by EDGAR at Jul 24, 2020, 16:31 ET.

Share

Management's discussion and analysis

As filed, 1,842 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Repurchase of Equity Securities

In April 2018, the Company’s Board of Directors authorized a stock repurchase program under which the Company may purchase up to $2.0 billion of the Company’s Common Stock during the three-year period ending April 24, 2021 (the “2018 Stock Repurchase Program”) in accordance with the requirements of Rule 10b-18 of the Securities Exchange Act of 1934, as amended. The Company did not repurchase any of its Common Stock during the three months ended June 30, 2020. The Company has not repurchased any additional shares of its Common Stock from July 1, 2020 to July 21, 2020, and has remaining authorization to purchase up to $587.9 million of its Common Stock under the 2018 Stock Repurchase Program. The price and timing of any future purchases under the 2018 Stock Repurchase Program will depend on a number of factors such as levels of cash generation from operations, the level of uncertainty relating to the COVID-19 pandemic, the volume of stock option exercises by employees, cash requirements for acquisitions, dividends, economic and market conditions and stock price.

The table below reflects the Company’s stock repurchases for the three months ended June 30, 2020:

(dollars in millions, except price per share)

​ ​ ​ ​ ​ ​ ​ ​ ​ Period ​ ​ ​ Total Number of Shares Purchased ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Average Price Paid per Share ​ ​ ​ ​ Total Number of ​ ​ Shares Purchased as ​ ​ Part of Publicly ​ ​ Announced Plans or ​ Programs ​ ​ Maximum Dollar Value of Shares that May Yet be Purchased Under the Plans or Programs ​
April 1 to April 30, 2020 — $— — $587.9 ​
May 1 to May 31, 2020 — ​ — — 587.9 ​
June 1 to June 30, 2020 — ​ — — 587.9 ​
Total — $— — $587.9 ​

Market risk

As filed, 1,908 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The Company, in the normal course of doing business, is exposed to a variety of risks, including market risks associated with foreign currency exchange rates and changes in interest rates. The Company does not have any significant concentration with any one counterparty. There has been no material change in the Company’s assessment of its sensitivity to foreign currency exchange rate risk since its presentation set forth in Part II, Item 7A “Quantitative and Qualitative Disclosures About Market Risk” in its 2019 Annual Report. From time to time, the Company may borrow under its Revolving Credit Facility and Commercial Paper Programs. Any borrowings under the Euro Commercial Paper Program, Revolving Credit Facility, 2026 Euro Notes and 2028 Euro Notes, as discussed in Note 4 of the accompanying Condensed Consolidated Financial Statements, are and may continue to be denominated in foreign currencies, and there can be no assurance that the Company can successfully manage these changes in exchange rates, including in the event of a significant and sudden decline in the value of any of the foreign currencies for which such borrowings are made. In addition, any borrowings under the Revolving Credit Facility either bear interest at or trade at rates that fluctuate with a spread over LIBOR, while any borrowings under the Commercial Paper Programs are subject to floating interest rates. Therefore, when the Company borrows under these debt instruments, the Company is exposed to market risk from exposure to changes in interest rates. As of June 30, 2020, there were no outstanding borrowings under the Revolving Credit Facility, U.S. Commercial Paper Program and Euro Commercial Paper Program. The Company does not expect changes in interest rates to have a material effect on income or cash flows in 2020, although there can be no assurances that interest rates will not change significantly.

Controls and procedures

As filed, 1,453 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures, pursuant to Rules 13a-15(e) or 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of the end of the period covered by this report. These controls and procedures are designed to provide reasonable assurance that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission rules and forms, and such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Based on their evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that the Company’s disclosure controls and procedures were effective as of the end of the period covered by this report.

Changes in Internal Control Over Financial Reporting

There has been no change in our internal control over financial reporting during the Company’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 5,076 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no material changes to the Company’s risk factors as disclosed in Part I, Item 1A. Risk Factors in our Annual Report on Form 10-K for our fiscal year ended December 31, 2019, other than the updates noted below.

We face significant risks related to health epidemics such as the COVID-19 pandemic, which could have material and adverse impacts on our business, financial condition, liquidity and results of operations.

Any outbreaks of contagious diseases and other adverse public health developments in countries where we operate could have a material and adverse effect on our business, financial condition, liquidity and results of operations. For example, the COVID-19 pandemic has caused widespread disruptions to our Company during both the second quarter and first six months of 2020. During the first quarter, these disruptions were primarily limited to our operations in China, which were closed for three weeks during January and February due to government mandates. As the virus spread to the rest of the world beginning in March and continuing throughout the second quarter of 2020, most of our other operations outside of China were then also impacted. As of June 30, 2020, we continue to experience disruptions, and at a minimum, we expect those disruptions to continue throughout the second half of 2020. These disruptions have included and may continue to include, depending on the specific location, government actions that limit our ability to operate certain of our facilities at full capacity or at all, government actions that limit our ability to adjust certain costs, travel restrictions, “work-from-home” orders and the gradual transition back to the workplace, limited availability of our workforce in some locations, supplier constraints, supply-chain interruptions, logistics challenges and limitations, and reduced demand from certain customers. The extent to which the COVID-19 pandemic will continue to impact our business and financial results going forward will be dependent on future developments such as the length and severity of the crisis, the potential resurgence of the crisis, future government actions in response to the crisis and the overall impact of the COVID-19 pandemic on the global economy and capital markets, among many other factors, all of which remain highly uncertain and unpredictable. In addition, the COVID-19 pandemic could impact the health of our management team and other employees. As of the date of this Quarterly Report on Form 10-Q, it is impossible to predict the overall impact of the COVID-19 pandemic on our business, financial condition, liquidity and financial results, and there can be no assurance that the COVID-19 pandemic will not have a material and adverse effect on our financial results during any quarter or year in which we are affected.

In addition to the above risks, the COVID-19 pandemic increases the likelihood and potential severity of other risks previously discussed in Item 1A. Risk Factors in our Annual Report on Form 10-K for our fiscal year ended December 31, 2019. These include, but are not limited to, the following:

  • A protracted economic slowdown could negatively affect the financial condition of our customers, which may result in an increase in bankruptcies or insolvencies, a delay in payments, and decreased sales.
  • A scarcity of resources or other hardships caused by the COVID-19 pandemic may result in increased nationalism, protectionism and political tensions which may cause governments and/or other entities to take actions that may have a significant negative impact on the ability of the Company, its suppliers and its customers to conduct business.
  • We have transitioned a significant subset of our employee population to a remote work environment in an effort to mitigate the spread of COVID-19. This change may exacerbate certain risks to our business, including an increased demand for information technology resources, an increased risk of phishing and other cybersecurity attacks, and an increased risk of unauthorized dissemination of sensitive personal information or proprietary or confidential information.
  • In recent months, the continued global spread of COVID-19 has led to disruption and volatility in the global capital markets, which at times has increased the cost of, and adversely impacted access to, capital (including the commercial paper markets) and increased economic uncertainty.
  • The COVID-19 pandemic has disrupted the supply of raw materials, and we may experience increased difficulties in obtaining a consistent supply of materials at stable pricing levels.
  • If the financial performance of our businesses were to decline significantly as a result of the COVID-19 pandemic, we could incur a material non-cash charge to our income statement for the impairment of goodwill and other intangible assets.
  • If there is a general market downturn and continued high degree of volatility in the financial markets, we may experience a material re-valuation of, for example, our pension assets and obligations.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2020-04-01 to 2020-06-30$1.99bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2020-01-01 to 2020-06-30$3.85bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2020-04-01 to 2020-06-30$1.38bnus-gaap:CostOfRevenue
Cost of revenue6 months2020-01-01 to 2020-06-30$2.69bnus-gaap:CostOfRevenue
Gross profit3 months2020-04-01 to 2020-06-30$603.8mus-gaap:GrossProfit
Gross profit6 months2020-01-01 to 2020-06-30$1.16bnus-gaap:GrossProfit
Selling, general and administrative3 months2020-04-01 to 2020-06-30$246.4mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2020-01-01 to 2020-06-30$489.3mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2020-04-01 to 2020-06-30$357.4mus-gaap:OperatingIncomeLoss
Operating income6 months2020-01-01 to 2020-06-30$674.3mus-gaap:OperatingIncomeLoss
Interest expense3 months2020-04-01 to 2020-06-30$30.2mus-gaap:InterestExpense
Interest expense6 months2020-01-01 to 2020-06-30$59.0mus-gaap:InterestExpense
Income tax3 months2020-04-01 to 2020-06-30$68.0mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2020-01-01 to 2020-06-30$114.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2020-04-01 to 2020-06-30$257.7mus-gaap:NetIncomeLoss
Net income6 months2020-01-01 to 2020-06-30$499.8mus-gaap:NetIncomeLoss
Diluted EPS3 months2020-04-01 to 2020-06-30$0.85us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2020-01-01 to 2020-06-30$1.64us-gaap:EarningsPerShareDiluted
Basic EPS3 months2020-04-01 to 2020-06-30$0.87us-gaap:EarningsPerShareBasic
Basic EPS6 months2020-01-01 to 2020-06-30$1.68us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2020-04-01 to 2020-06-30304,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2020-01-01 to 2020-06-30305,200,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2020-01-01 to 2020-06-30$752.4mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2020-01-01 to 2020-06-30$128.3mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid3 months2020-04-01 to 2020-06-30$74.0mus-gaap:PaymentsOfDividendsCommonStock
Dividends paid6 months2020-01-01 to 2020-06-30$148.4mus-gaap:PaymentsOfDividendsCommonStock
Share repurchases6 months2020-01-01 to 2020-06-30$257.2mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2020-06-30$1.29bnus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-06-30$4.62bnus-gaap:AssetsCurrent
Total assetsAt period end2020-06-30$11.20bnus-gaap:Assets
Current liabilitiesAt period end2020-06-30$1.79bnus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2020-06-30$4.74bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001558370-20-008390. Last ingested by Listed: Nov 3, 2026, 18:42 ET. Listed shows no prices and gives no investment advice.